“We are incredibly pleased with our collaboration withZai Labgiven their strong enrollment into the global TRIDENT-1 study and are happy to share these initial results,” saidMohammad Hirmand, M.D., Chief Medical Officer ofTurning Point Therapeutics. “We look forward ...